Vitamin D status and its correlation to depression

Bashir khan; Huma Shafiq; Seyyedha Abbas; Summeira Jabeen; Sikandar Ali Khan; Tayyaba Afsar; Ali Almajwal; Nawaf W Alruwaili; Dara al-disi; Sultan Alenezi; Zahida Parveen; Suhail Razak

doi:10.1186/s12991-022-00406-1

. 2022 Aug 18;21:32. doi: 10.1186/s12991-022-00406-1

Vitamin D status and its correlation to depression

Bashir khan ¹, Huma Shafiq ², Seyyedha Abbas ¹, Summeira Jabeen ¹, Sikandar Ali Khan ¹, Tayyaba Afsar ³, Ali Almajwal ³, Nawaf W Alruwaili ³, Dara al-disi ³, Sultan Alenezi ², Zahida Parveen ⁴, Suhail Razak ^3,^✉

PMCID: PMC9389668 PMID: 35982462

Abstract

Background

Vitamin D can influence more than 200 genes in various tissues showing its credibility among the fat-soluble vitamins. Vitamin D deficiency is directly proportional to major clinical conditions such as cardiovascular diseases, diabetes, malignancy, and multiple sclerosis. This study was conducted to determine the vitamin D level of individuals and its association with depression.

Methods

Vitamin D levels of 100 healthy and 100 depressed subjects were determined. The isolated subjects were screened on the Beck Depression Inventory (BDI) scale and divided into three groups according to their age. Group-I comprised subjects of age 20 years and below, Group-II included subjects of age 21 to 60, and Group-III comprised subjects of ≥ 61 years of age. A sufficient level of vitamin D in normal subjects was noted, while mild deficiency of vitamin D status was observed in depressed subjects.

Results

Our study has reported a higher percentage of vitamin D deficiency in the Peshawar region. The results of our study indicated that depression was common in individuals having vitamin D deficiency.

Conclusions

The study showed a very high frequency of vitamin D deficiency in subjects with depression in Peshawar, Pakistan. The deficiency of vitamin D was observed more in females as compared to males. Further studies should explicate whether the highly widespread vitamin D deficiency could be cost-effectively treated as part of preventive or treatment interventions for depression.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12991-022-00406-1.

Keywords: Vitamin D, Beck depression inventory, Tyrosine hydroxylase and depression

Background

Vitamin D is also known as a secosteroid hormone known for its vital role in maintaining the normal function of bones. Research regarding the specific role of vitamin D in the immune system has been discovered. Vitamin D can influence more than 200 genes in various tissues, showing its credibility among the fat-soluble vitamins. Vitamin D deficiency is directly proportional to primary clinical conditions such as cardiovascular diseases, diabetes, malignancy and multiple types of scleroses [25]. Therefore, clinicians recommend large intake of vitamin D in the Diet so as to prevent these significant clinical conditions [22, 31]. Vitamin D deficiency exists throughout the world in various populations, including children, adults, both male and female (pregnant and lactating), and those who often avoid sunlight exposure. It is worth mentioning that individuals who have darkly pigmented skin are more prone to vitamin D deficiency [10].

Food is a limited source of vitamin D. Hence, overcoming the deficiency of vitamin D through food will not be sufficient. However, vitamin D supplements could be used to control its deficiency, but their efficacy is inconsistent and variable [10]. It has been noticed that vitamin D level is low in those individuals who have a mood disorder, and its mechanism of action has been noticed in causing depression [44, 52]. Vitamin D synthesis in the fair skin is enormously fast and significant even after a few minutes of exposure to sunlight [24]. Incidental sun exposure is the major and prominent source of circulating vitamin D [23, 43]. Upon exposure to sunlight in the summer season, Fair Skin can produce about 20,000 IU of vitamin D in less than 30 min [26]. A study conducted in the US in 89 different geographical locations on a large population suggested that the incidence of depression is greater in those people who have deficient vitamin D levels instead in those who have normal vitamin D levels [20].

Vitamin D has a key role in preventing rickets in children and reduces the risks of cancer, multiple sclerosis, and bacterial infections [21, 45]. Vitamin D deficiency leads to diabetes mellitus; its deficiency causes a decrease in microglial inflammatory function leading to increased brain infections [3, 29, 41. Zittermann et al. in 2003 and McCann and his colleagues in 2008 have revealed a significant correlation between vitamin D deficiency and brain dysfunctions [35, 54]. Vitamin D has a crucial role in developing a normal brain, while its deficiency is associated with morphological changes, such as enlarged ventricles and decreased cortical thickness [2, 18]. For about 30 years, a complicated interaction has been described between neuroinflammation, immune activation and modifications in brain circuits associated to depression and anxiety [34]. Therefore, vitamin D is known for regulation of innate immunity, both as a transcription and growth factor by interrelating with surface receptors in diverse immune cells [5]. Vitamin D is, therefore, associated with its ability to regulate both immune responses of peripheral and central nervous systems [46].

The antimicrobial properties of vitamin D has been described as its first immune-related properties, but it is also involved in the modulation of both innate and adaptive immune reactions [5]. In this perspective, depression and anxiety are often related with a low-grade inflammatory significance and peripheral increase in acute-phase proteins and inflammatory cytokines [17].

It is observed that vitamin D regulates the gene expression for one of the essential enzymes Tyrosine Hydroxylase, which is involved in synthesizing dopamine and norepinephrine. These neurotransmitters are famous for their role in depression and mood disorders [40]. Vitamin D maintains physiological functions, such as calcium homeostasis, membrane permeability and axonal conduction, and neurotransmission [11]. Vitamin D stimulates the receptors in those regions of the brain concerned with the regulation of emotion and behavior, such as the limbic system, cortex, and cerebellum. It also stimulates the release of neurotrophin, which has an important role in the regulation of neuronal development [39].

The ideal level of serum 25(OH) D levels lies between 100 and 150 nmol/L. Below 50 nmol/L are related to vitamin D deficiency; between 50 and 75 nmol/L levels are associated with moderate vitamin D deficiency. The criteria for interpretation of vitamin D values are divided into four main categories: vitamin D deficiency (less than 20 ng/mL), vitamin D insufficiency (21–29 ng/mL), vitamin D sufficiency (equal to or more than 30 ng/mL), vitamin D intoxication (more than 150 ng/mL) [12].

Emerging data from mouse models and human findings proposed that vitamin D showed potent immunosuppressant activity and might stimulate proinflammatory cytokines, for example IL-6 in the brain [49]. Vitamin D has numerous effects on the CNS to act as mood modulator, apart from the wide distribution of vitamin D receptors in brain regions closely implicated in depression and anxiety disorders pathophysiology. Though, further studies are required to clarify the mechanisms associated with mood improvement and to find out the groups of patients who might be benefited from vitamin D supplementation [5].

Mukesh and his colleagues determine the vitamin D level in the people of Pakistan [8]. This study was conducted to determine the vitamin D level of individuals with depression and the relationship of vitamin D with depression. Menon et al. showed low vitamin D levels in the population with depression [36]. Unfortunately, the issue of vitamin D level deficiency has been ignored in Pakistan. Hence, we identified the conclusion with the objective to find the significance of vitamin D level with depression.

Methods

Participants

A total of 200 subjects, including 100 healthy individuals and 100 depressed individuals (outpatients), were selected from various areas of Peshawar, Pakistan, at Cantonment Board Hospital Peshawar, Khyber Teaching Hospital Peshawar, and Lady Reading Hospital Peshawar. The selected individuals between 20 and below to 60 and above 60 years, were properly screened on BDI scale. Informed consent was taken from all participants included in the study. The study protocol was approved by the ethics committee in the Shaheed Benazir Bhutto Women University, Peshawar, Khyber Pakhtunkhwa, Pakistan. Studies reported in the manuscript fully meet the criteria for animal studies specified in the ACS ethical Guidelines.

Study protocol

After taking their consent, all the participants were screened for inclusion in the study. Their blood samples were collected properly to determine their vitamin D level.

Study design (descriptive)

All the necessary relevant information to the study participants was collected with informed written consent from the institutional review board and approved criteria for survey. Information about their vitamin D level and depression were compared to establish a relation between the two.

Inclusion criteria

Participants of varied age with vitamin D deficiency and mild to severe depression were included in the study.

Exclusion criteria

Study participants with chronic diseases such as liver and renal diseases, malabsorption syndrome, and other diseases that can affect the level of vitamin D were excluded from the study.

Sampling technique

Collection of blood samples

Blood samples (3 mL) were collected from subjects, labelled, and stored in vials at 4°C. The tubes were centrifuged (Megafuge 1.0, Heraeus Sepatech) at 5000 rpm for 10 min. The blood serum was analysed for vitamin D level.

Determination of vitamin D level

For vitamin D determination, serum was separated. The serum level of vitamin D is monitored in Architect Plus, Abbott. The recorded data was noted automatically and further processed on the instrument CI 4100, where vitamin D level was determined and reported in ng/mL. The reference ranges are given in Additional file 1: Table S1 [19].

Identification of depressed and normal subjects

Depressed and normal subjects were initially identified by examining the patients for their mood and history. After preliminary identification of depressed subjects, their level of depression was further measured.

Estimation of level of depression

The level of depression in all the 100 depressed patients identified was determined using BDI scale described by Beck et al. [7]. BDI questionnaire contains 21 groups of statements necessary for estimating the depression level of subjects. Thus, in a typical experimental procedure, the most appropriate statement with all three groups were encircled by getting the history of the depressed subjects. The filled questionnaire was scored, and the level of depression was determined from the score as shown in Additional file 1: Table S2 [1].

Results

To find the relation between vitamin D level and depression, the vitamin D levels of 100 healthy subjects and 100 depressed subjects were determined, as shown in Table 1. They were divided into three groups according to their age, i.e., Group-I comprised subjects below 20 years and below 20 years, Group-II included subjects between 21 and 60 years, and Group-III comprised of subjects above 61 years and above 61 years, and observation has been recorded, respectively.

Table 1.

Comparative vitamin D level of total normal (100) and total depressed (100) subjects determined in nanogram per milliliter (ng/mL) given as mean ± SEM

S. No	Parameters	Subjects		p value
S. No	Parameters	Normal (ng/mL)	Depressed (ng/mL)	p value
1	Mean	46.34	23.60	< 0.05
2	Standard deviation	39.1	11.9
3	Standard error of mean	3.91	1.2
4	Coefficient of variance (%)	84.30	50.42

Open in a new tab

P ≤ 0.05 = significant; P > 0.05 = non-significant

Vitamin D profile of 100 normal subjects (males and females)

Table 2 shows the age and vitamin D data obtained for 100 normal male and female subjects. The mean ± SEM of the age of the normal male of 59 subjects was 39.28 ± 2.27 and the coefficient of variation (CV) of age was found as 44.42%. While the mean ± SEM of vitamin D level was found as 34.65 ± 3.84 and 84.84% CV.

Table 2.

Age vitamin D level of normal male (59) and female (41) subjects determined in nanogram per milliliter (ng/mL) given as mean ± SEM

S. No	Parameters	Males (59)		Females (41)		p value	P value Vitamin D
S. No	Parameters	Age (years)	Vitamin D ng/mL	Age (years)	Vitamin D ng/mL	Age	P value Vitamin D
1	Mean	39.28	34.65	45.82	61.45	< 0.05	< 0.05
2	Standard deviation	17.45	29.4	14.56	45.86
3	Standard Error of mean	2.27	3.82	2.3	7.16
4	Coefficient of variance (%)	44.42	84.84	31.79	74.62

Open in a new tab

P ≤ 0.05 = significant; P > 0.05 = non-significant

Similarly, the age and vitamin D data of all normal female 41 subjects revealed that the mean ± SEM of age is 45.82 ± 2.3 with 31.79% CV, while 61.45 ± 7.16 was the mean ± SEM of vitamin D level and CV was observed 74.62%. The p value of age (p < 0.05) and p value of vitamin D (p < 0.05) are given.

Age, vitamin D and depression profile of 100 subjects with depression (male and female)

Table 3 shows the age, vitamin D, and depression profile of 41 male subjects with depression. The data given in the table indicated the mean ± SEM of age is 38.87 ± 2.089, and 34.41% is the CV. The mean ± SEM of vitamin D level given is 24.17 ± 1.32 with a 34.96% CV. The mean ± SEM of depression level on the BDI scale given in the table is 25.8 ± 1.49 with a 37.17% CV.

Table 3.

Age vitamin D level and BDI score of the male (41) and female (59) patients determined in nanogram per milliliter (ng/mL) given as the mean ± SEM

S. No	Parameters	Males			Females			p value
S. No	Parameters	Age (years)	Vitamin D, ng/mL	BDI score	Age (years)	Vitamin D, ng/mL	BDI score	p value
1	Mean	38.87	24.17	25.8	45.5	23.36	28.06	< 0.05	> 0.05
2	Standard deviation	13.37	8.45	9.59	14.36	13.95	7.26
3	Standard error of mean	2.09	1.32	1.49	1.87	1.81	0.95
4	Coefficient of variance (%)	34.41	34.96	37.17	31.56	59.76	25.86

Open in a new tab

P ≤ 0.05 = significant P > 0.05 = non-significant

Table 3 presents the age, vitamin D, and depression profile of all 59 female subjects with depression. The data obtained demonstrated the mean ± SEM of age as 45.5 ± 1.87 and 31.56% CV. The mean ± SEM of vitamin D level given is 23.36 ± 1.81 and 59.76% CV. The mean ± SEM of depression given is 28.06 ± 0.95, and 25.86% is the CV. The p value of age (p < 0.05) and p value of vitamin D was (p > 0.05) are given. The p value of age is significant, while that vitamin D is non-significant.

Depression and vitamin D profile of subjects of 20 years and below (Group-I)

In Group-I (Table 4), subjects of 20 years and below comprising of 10 normal and 4 subjects with depression were evaluated for their vitamin D and depression level. For the 10 normal subjects, the mean ± SEM of age found was 15.9 ± 0.6 with a 12.01% CV. For vitamin D level, the mean ± SEM was calculated as 17.67 ± 0.56, and the CV was found as 9.91%.

Table 4.

Age vitamin D level of normal and depressed along with BDI score of subjects 20 years of age and below of (Group I) given as the mean ± SEM

S. No	Parameters	Normal subjects		Depressed subjects			P value	p value
S. No	Parameters	Age	Vitamin D (ng/mL)	Age	Vitamin D (ng/mL)	BDI score	Age	vitamin D
1	Mean	15.9	17.67	17.75	23.2	19.0	> 0.05	> 0.05
2	Standard deviation	1.91	1.76	2.5	2.12	6.21
3	Standard error of mean	0.6	0.56	1.23	1.06	3.1
4	Coefficient of variance (%)	12.01	9.91	41.08	9.14	32.7

Open in a new tab

P ≤ 0.05 = significant; P > 0.05 = non-significant

The depression and vitamin D profile of the 4 depressed subjects (Table 4) of this group showed mean ± SEM of vitamin D level as 23.2 ± 1.06, and 9.14% was recorded as the CV. The mean ± SEM of BDI score was calculated as 19 ± 3.1, and of age was calculated as17.75 ± 1.43. The p value of age (p > 0.05) and p value of vitamin D (p > 0.05) are non-significant.

Depression and vitamin D profile of subjects between 21 and 60 years (Group-II)

Table 5 discusses the statistics of all the 70 normal subjects. The mean ± SEM of the age of 40 normal subjects determined was 39.18 ± 5.83 with a 14.9% CV. The mean ± SEM of vitamin D level of the 40 normal subjects was calculated as 44.51 ± 4.21 ng/mL, and the CV was 79.16%.

Table 5.

Age vitamin D level of normal and depressed subjects of age 21 to 60 years of both sexes belonging to (Group II) given as the mean ± SEM

S. No	Parameters	Normal subjects		Depressed subjects			p value	p value
S. No	Parameters	Age	Vitamin D (ng/mL)	Age	Vitamin D (ng/mL)	BDI score	Age	Vitamin D
1	Mean	39.18	44.51	39.35	24.1	26.78	> 0.05	< 0.05
2	Standard deviation	48.79	35.24	9.78	12.89	8.6
3	Standard error of mean	5.83	4.21	1.09	1.44	0.96
4	Coefficient of variance (%)	14.87	79.16	24.85	53.48	32.11

Open in a new tab

P ≤ 0.05 = significant; P > 0.05 = non-significant

For the group of age 21–60 years, the mean ± SEM of ages of all 80 subjects with depression were statistically determined as 39.35 ± 1.09, and the CV was calculated as 24.85%. The mean ± SEM of vitamin D level of all subjects was statistically calculated as 24.1 ± 1.44 ng/mL. The CV was determined as 32.1%, respectively, while 26.78 ± 0.96 as the mean ± SEM of depression (Table 5). The p value of age (p > 0.05) is non-significant and p value of vitamin D (p < 0.05) is significant.

Among all the depressed subjects, the vitamin D levels of 16 subjects (20%) were found normal, while vitamin D of 40 subjects (50%) was mildly deficient, and 24 subjects (30%) with depression were severely deficient in vitamin D level.

The relations between vitamin D and depression level in subjects with depression of age group 21 to 60 years of age have been summarized in Table 5. A total of 80 subjects were selected which were declared as depressed after examining them on the BDI scale.

All subjects with depression were scrutinized thoroughly on BDI scales to find their level of depression. It was found that 23 (28.7%) of them were mildly depressed, 19 subjects (23.7%) with moderate depressed and 38 subjects (47.5%) were found severely depressed. The moderate depressed 19 subjects (23.7%) were also examined for their vitamin D level, and significant results were found, 6 subjects (31.57%) had a severe deficiency of vitamin D, 10 subjects (52.6%) were found with mild deficiency, and only 3 subjects (15.7%) were having normal levels of vitamin D.

The other 38 subjects (47.5%) who were found as severely depressed on the BDI scale were also examined for their vitamin D level showed that 15 subjects (39.4%) had a severe deficiency of vitamin D, 16 subjects (42.1%) were found with moderate deficiency, and only 7 subjects (18.4%) had normal levels of vitamin D. In this age group an interesting relation between vitamin D and depression was noticed in the subjects. The results indicated the decrease in vitamin D levels was observed with increasing severity of depression calculated by the BDI scale.

The cumulative correlation between vitamin D and depression levels of all the mild, moderate, and severely depressed subjects, vitamin D levels of 20 subjects (25%) were found normal. A total of 28 subjects (35%) among the patients with depression showed a mild vitamin D deficiency, and 32 subjects (40%) with depression showed severe deficiency in their vitamin D levels. Moreover, the mean vitamin D of all the subjects with depression was found to be 24.1 ± 1.44 ng/mL, which is at the lower limit of mild deficiency and close to the upper margin of severe deficiency of vitamin D level with 53.48% CV.

Statistical analysis of BDI score of depression showed mean ± SEM, BDI score was 26.78 ± 0.96, which is the upper limit of moderate depression and approaching the least limits of severe depression. A 30.02% variation was recorded from the upper limit of the moderate depression showing 70% depression in the depressed subjects as at the upper level of moderate depression (Table 5).

The work was further continued to determine the relationship between the vitamin D level of normal and subjects with depression of age 21–60 years (Table 5). In the normal subjects, the mean ± SEM of vitamin D level was found to be 44.51 ± 4.21 ng/mL, and CV calculated was, respectively. While the mean of vitamin D level of subjects with depression was 23.15 ng/mL, considered as the mild deficiency of vitamin D. The CV of this level was calculated was 43.23% showed greater variation (Table 5).

Depression and vitamin D profile of 61 years and above subjects (Group III)

In the 3rd group, 20 healthy and 16 subjects with depression of 60 years and above were selected (Table 6). For the 20 healthy subjects, mean ± SEM of age was found as 65.65 ± 1.06, while the mean ± SEM of vitamin D calculated was 64.09 ± 11.96 and 7.2% and 83.5% was found as a CV in age and vitamin D level, respectively (Table 6).

Table 6.

Age vitamin D level of normal and depressed subjects of 61 years of age and above belonging to (Group III) given as the Mean ± SEM

S. No	Parameters	Normal subjects		Depressed subjects			p value	p value
S. No	Parameters	Age	Vitamin D (ng/mL)	Age	Vitamin D (ng/mL)	BDI score	Age	Vitamin D
1	Mean	65.65	64.09	66.25	21.8	30.94	> 0.05	< 0.05
2	Standard deviation	4.73	53.51	4.90	6.84	5.14
3	Standard error of mean	1.06	11.96	1.22	1.7	1.3
4	Coefficient of variance (%)	7.2	83.5	7.4	13.4	16.61

Open in a new tab

P ≤ 0.05 = significant; P > 0.05 = non-significant

All the 16 subjects with depression were analyzed on the BDI scale in which 4 subjects were found with moderate depression, and twelve were having severely depression. Among the subjects with moderate depression, a vitamin D level of 1 was severe deficient, two were mildly deficient, and a vitamin D level of 1 was found normal (35.0 ng/mL). In the remaining 12 subjects with severe depression, the vitamin D level of 8 subjects was found to be mildly deficient, and three were severely deficient. While one subject showed a normal level of vitamin D. Here, an important correlation was observed between vitamin D levels and depression.

Statistical analysis of subjects shows the mean ± SEM of age 66.25 ± 1.2, while the mean ± SEM of vitamin D level was 21.8 ± 1.7in subjects having depression of age 60 and above. This value is very close to the severe deficiency of vitamin D level. On the other hand, on the BDI scale, 75% of the patients were with severe depression.

Furthermore, the mean ± SEM of BDI score was found to be 30.94 with a ± 5.14 standard deviation, which is the lower margin of severe depression. It is to be noted here that 13.4% variations from the mean vitamin D level suggest a more significant deficiency of vitamin D in subjects with depression in this case. Similarly, 16.6% variation from the mean BDI score was observed, which showed a strong correlation between vitamin D and depression.

Table 6, showing p value of age (p > 0.05) and p value of vitamin D (p < 0.05), p value of age is non-significant, while vitamin D is significant. Table 7 shows the vitamin D profile of all 100 normal subjects in which 59 (59%) subjects were male, and 41 (41%) female subjects irrespective of their age. Out of 100 normal subjects, 38 (38%) had normal vitamin D levels, of which 23 (60.5%) were female and 15 (39.5%) were male subjects. While 36 (36%) subjects had mild vitamin D levels, in which 6 (16.7%) were female, and 30 (83.3%) were male subjects. In Table 6 (17%), subjects had severe vitamin D deficiency, in which 6 (35.3%) were female, and 11 (64.7%) were male subjects. In all total 100 subjects, 9 (9%) showed a toxic level of vitamin D, of which 6 (66.7%) were female, and 3 (33.3%) were male.

Table 7.

Vitamin D level of normal, depressed and depression status of depressed subjects has been mentioned as the mean ± SEM

		Vitamin D level							Depression level
S.No		Normal subjects			Depressed subjects				Depressed subjects
		Total	Male	Female	Total	Male	Female	Status	Total	Male	Female
1	Status	100	59	41	100	41	59		100	41	59
2	Normal level	38	15 (40)	23 (60)	19	07 (37.0)	12 (63.0)	Mildly depressed	26	16 (62.0)	10 (38.0)
3	Mildly deficient	36	30 (83.0)	06 (17)	51	27 (53.0)	24 (47.0)	Moderately depressed	24	08 (33.0)	16 (67.0)
4	Severely deficient	17	11 (65)	06 (35)	30	07 (23.0)	23 (77.0)	Severely depressed	50	17 (34.0)	33 (66.0)
5	Toxic level	09	03 (33.0)	06 (67)	–	–	–		–	–	–

Open in a new tab

Table 7 shows the vitamin D profile of all 100 subjects with depression, of which 59 (59%) subjects were female and 41 (41%) male subjects irrespective of their age. In all 100 subjects, 19 (19%) showed normal vitamin D levels, of which 12 (63.2%) were female, and 7 (36.8%) were male subjects. While 51 (51%) showed a mild deficiency of vitamin D level, in which 24 (47.1%) were female, and 27 (52.9%) were male subjects. In the same table 30 (30%) subjects were having severe vitamin D deficiency, in which 23 (76.7%) were female, and 7 (23.3%) were male subjects.

The depression profile of all 100 subjects with depression irrespective of their age. Table 7 indicates that out of 100 subjects, 26 (26%) were having mild depression, of these 26 subjects were having mild depression 10 (38.5%) were female, and 16 (61.5%) were male subjects. While 24 (24%) subjects were having moderate depression, in which 16 (66.7%) subjects were female, and 8 (33.3%) were male. In the same table, 50 (50%) subjects were having severe depression, in which 33 (66%) subjects were female, and 17 (34%) were male.

Discussion

Vitamin D is a steroid hormone that performs various essential roles in the body, including its psychological roles [47]. Pakistan is in a Tropical region; hence sunlight is received by the people insufficiently amount, and people mostly avoid indoor activities. Many people living in Pakistan is unaware of the importance of the natural existence of vitamin D in sunlight and in daily food intake. Such factors should be taken into consideration. Vitamin D is known for its main function, which is the regulation of calcium and phosphorus concentration in the bones to facilitate cellular, neuromuscular, and ossification function [47]. Vitamin D deficiency can cause rickets in children, while osteomalacia in adults, osteoporosis, cancer, diabetes and autism results from vitamin D deficiency [37]. Treating vitamin D deficiency and the diseases such as cancer, multiple sclerosis, cardiovascular diseases require vitamin D supplements [9]. The Canadian guidelines for recommended dietary intake of vitamin D suggest 600 International Units for individuals aged 1 to 70 years and 800 IU for 71 years of age and above [53].

Hoogendijk et al. proposed the possible role of vitamin D in the brain [29]. Vitamin D is one of the secosteroid hormones that can pass through the blood–brain barrier (BBB), and its receptors are located in different regions of the brain, such as the cortex cerebellum and limbic system. It is proposed that a low level of vitamin D can lead to the elevation of PTH, which is associated with depression. Mainly, depression can be treated by treating hyperthyroidism [28].

Vitamin D deficiency has been observed in developed and developing countries including the US and Europe [38]. In the US, 36% of the adults with vitamin D deficiency has been observed [42]. In Australia, 1 in every 3 people has vitamin D deficiency [15]. In Pakistan, the prevalence of vitamin D deficiency in children is serious as 41% [16]. A study conducted in Faisalabad to determine vitamin D level reported that an epidemic in females as 87% of the pregnant females were found with vitamin D deficiency [4]. In another study, 90.1% of premenopausal females were presented with vitamin D deficiency in Karachi [30].

In this study vitamin D levels were noted within normal range in healthy subjects, while below normal ranges were observed in depressed subjects (Table 3). The study has reported some of the higher frequency of vitamin D deficiency in Peshawar region, with symptoms of depression. Significantly [32]. Patients with severe deficiency were above 70 years of age and more likely had mood disorder. Vitamin D deficiency has been concerned with anxiety and depression, although different researches have shown varied results. A strong association studies by Bernard and Hoogendijk demonstrated in elderly, hypovitaminosis D as a risk factor for depressive disorder in population-based cohorts [27]. Our results are in consistency that adults aged 20 or older did not find any relationship between hypovitaminosis D and depression as in group I.

The high prevalence of vitamin D deficiency in females might be, because they are not exposed to sunlight properly and are mostly housewives involved maximum time in domestic work. Females mostly wear hijab and burqa, due to which they are less exposed to the sunlight. The lack of awareness about a healthy lifestyle and lack of cooking expertise are contributing factors to the prevailing vitamin D deficiency. The pledge of government towards society is required to combat the condition. A national program on vitamin D supplementation and a public awareness campaign is urgently needed [30]. The results of this study indicated that vitamin D deficiency is associated with an increased risk of depression in isolated subjects.

Depression and other mood disorders are major health concerns throughout the world. It sheds very negative impacts on the quality of life, and it has been estimated that by 2020 depression will be ranked as second in global health burdens to the heart diseases [33]. Depression is characterized as persistent low mood, sadness, and hopelessness with pessimism. The effectiveness of depression sometimes ends their life, committing suicide [33].

Vitamin D deficiency is linked with the development of mood disorders by Stone and colleagues in 2012. It was proposed that vitamin D supplements may play a role in the treatment of depression [48]. However, low levels of vitamin D may be contributed to uncontrolled mood and behavior. The deficiency can damage brain health and thus cognitive function.

People with depression live a very disturbing life. They feel tired and thus are unable to perform their routine life activities. Their family life is also disturbed, and their vitamin D levels is low [50]. In the US, depression is considered a leading cause of disability in the young population [48].

This study allowed to understand the combination of anti-depressant and psychotherapy used as a conventional treatment for depression during vitamin D deficiency [50]. The exercise can be an effective intervention in the reduction of depressive symptoms. Complementary and alternative medical interventions for depression include omega-3 essential fatty acids, tryptophan, adenosylmethionine, folic acid, vitamin B12, and zinc [13]. Therefore, the prevalence of vitamin D deficiency and its multi-system implications, the serum calcium level, and phosphorus do not predict its deficiency because of the limited studies available in Pakistan. Further implications must be applied to initiate the advanced research work.

Conclusions

The study showed a very high frequency of vitamin D deficiency in the subjects with depression in Peshawar, Pakistan. Vitamin D deficiency was observed more in females as compared to males. In this study, the correlation between vitamin D and depression was tried to ascertain, and it has been observed that prevalence of depression is common in those individuals who have a low level of vitamin D. The growing data of vitamin D deficiency in Pakistan may appear surprising, since we receive ample sunshine almost all year round.

Limitations of our study

A limitation is the progress of the cohort of this study. Since, subjects included were vitamin D deficient. As compared to the general population, there should be potential bias for indicative patients with low vitamin D level. In addition, due lack of data, we could not able to determine differences of ages with vitamin D levels. However, our study might help further to analyse the degree of vitamin D deficiency and its association with anxiety and major depressive disorder.

Supplementary Information

12991_2022_406_MOESM1_ESM.docx^{(16.5KB, docx)}

Additional file 1: Table S1. Reference Ranges for 25 (OH) D (Ferrari, Lombardi, & Banfi, 2017).

Acknowledgements

The authors extend their appreciation to the Researchers Supporting project number (RSP2022R502), King Saud University, Riyadh Saudi Arabia for funding this project.

Abbreviations

BDI: Beck depression inventory
CV: Coefficient of variation
SEM: Standard error

Author contributions

BK, HS, SB, SA, SR, SJ, TA, NWA, SR and AA, made significant contributions to conception, design, experimentation, acquisition, and interpretation of data and writing of the manuscript. BK, HS, SB, SA, ZP, SR, SJ, TA, NWA, SR, DA and AA made substantial contributions to the interpretation of data and revising the manuscript for intellectual content. All authors read and approved the final manuscript.

Funding

The authors extend their appreciation to the Researchers Supporting project number (RSP2022R502), King Saud University, Riyadh Saudi Arabia for funding this project.

Availability of data and materials

All the data is contained in the manuscript.

Declarations

Ethical approval and consent to participate

The study protocol was approved by the ethics committee in the Shaheed Benazir Bhutto Women University, Peshawar, Khyber Pakhtunkhwa, Pakistan. Studies reported in the manuscript fully meet the criteria for animal studies specified in the ACS ethical Guidelines. Informed consent was taken from all participants included in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Bashir khan, Email: dr.bashirkhan84@yahoo.com.

Huma Shafiq, Email: mmg04_31pu@yahoo.com.

Seyyedha Abbas, Email: syedhabia@gmail.com.

Summeira Jabeen, Email: dr.sumairajabeen@yahoo.com.

Sikandar Ali Khan, Email: siki4sikandar@gmail.com.

Tayyaba Afsar, Email: tayyaba_sona@yahoo.com.

Ali Almajwal, Email: Aalmajwal@ksu.edu.sa.

Nawaf W. Alruwaili, Email: nawaf.alwanas@gmail.com

Dara al-disi, Email: daldisi@ksu.edu.sa.

Sultan Alenezi, Email: Salenezi@ksu.edu.sa.

Zahida Parveen, Email: Zahida.parveen@alvotech.com.

Suhail Razak, Email: smarazi@ksu.edu.sa.

References

1.Allen CK, Austin SL, David SK, MHE O, McCraith Riska-Williams DB. Manual for the allen cognitive level screen-5 (ACLS-5) and large allen cognitive level screen-5 (LACLS-5) LJJOT. 2007;56:609–639. [Google Scholar]
2.Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Féron F. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics. 2007;7(5):769–780. doi: 10.1002/pmic.200600392. [DOI] [PubMed] [Google Scholar]
3.Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum SJC. The role of vitamin D in brain health a mini literature review. Cureus. 2018 doi: 10.7759/cureus.2960. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Aslam M, Masood Z, Sattar A, Qudsia M. Vitamin D deficiency. Prof Med J. 2012;19(02):208–213. [Google Scholar]
5.Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu CJC. Vitamin D modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–496. doi: 10.1016/j.coph.2010.04.001. [DOI] [PubMed] [Google Scholar]
6.Barnard K, Colón-Emeric CJTA. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010;8(1):4–33. doi: 10.1016/j.amjopharm.2010.02.004. [DOI] [PubMed] [Google Scholar]
7.Beck AT, Steer RA, Brown GK. Beck depression inventory (BDI-II) London: Pearson; 1996. [Google Scholar]
8.Bhimani MMJJ. Vitamin D does it play a role in psychiatry. J Pak Med Assoc. 2012;62(2):181. [PubMed] [Google Scholar]
9.Bosomworth N. Mitigating epidemic vitamin D deficiency: the agony of evidence. Can Fam Phys. 2011;57(1):16–20. [PMC free article] [PubMed] [Google Scholar]
10.Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008;13(1):6. [PubMed] [Google Scholar]
11.Chamorro L, Luque A, Lobo A. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton Anxiety rating scales. Med Clin. 2002;118(13):493–499. doi: 10.1016/S0025-7753(02)72429-9. [DOI] [PubMed] [Google Scholar]
12.Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Hoshen MBJB. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014 doi: 10.1136/bmj.g1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exerc Psychol. 1998;20(4):339–357. doi: 10.1123/jsep.20.4.339. [DOI] [Google Scholar]
14.Cusin C, Yang H, Yeung A, Fava M. Rating scales for depression. In: Lee B, Mark AB, editors. Handbook of clinical rating scales and assessment in psychiatry and mental health. Totowa: Humana Press; 2009. [Google Scholar]
15.Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Shaw JE. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol. 2012;77(1):26–35. doi: 10.1111/j.1365-2265.2011.04320.x. [DOI] [PubMed] [Google Scholar]
16.Di Cesare M, Bhatti Z, Soofi SB, Fortunato L, Ezzati M, Bhutta ZA. Geographical and socioeconomic inequalities in women and children's nutritional status in Pakistan in 2011: an analysis of data from a nationally representative survey. Lancet Glob Health. 2015;3(4):e229–e239. doi: 10.1016/S2214-109X(15)70001-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
17.Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KLJ. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi: 10.1016/j.biopsych.2009.09.033. [DOI] [PubMed] [Google Scholar]
18.Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience. 2003;118(3):641–653. doi: 10.1016/S0306-4522(03)00040-X. [DOI] [PubMed] [Google Scholar]
19.Ferrari D, Lombardi G, Banfi GJ. Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement. Biochemia Medica. 2017;27(3):453–466. doi: 10.11613/BM.2017.030501. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Ganji V, Milone C, Cody MM, McCarty F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the third national health and nutrition examination survey. Int Arch Med. 2010;3(1):1–8. doi: 10.1186/1755-7682-3-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–261. doi: 10.2105/AJPH.2004.045260. [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Harvey NC, Cooper C. Vitamin D: some perspective please in british medical journal publishing group. BMJ. 2012 doi: 10.1136/bmj.e4695. [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Holick MF. Photosynthesis of vitamin D in the skin effect of environmental and life-style variables. In: Federation proceedings, Vol. 46, No. 5; 1987. p. 1876–1882. [PubMed]
24.Holick MF. High prevalence of vitamin D inadequacy and implications for health paper presented at the Mayo. Clin Proc. 2006 doi: 10.4065/81.3.353. [DOI] [PubMed] [Google Scholar]
25.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]
26.Hollis BW, Wagner CL. Vitamin D deficiency during pregnancy an ongoing epidemic. Oxford: Oxford University Press; 2006. [DOI] [PubMed] [Google Scholar]
27.Hoogendijk W, Beekman A, Deeg D, Lips P, Penninx BJ. Depression is associated with decreased 25-hydroxyvitamin-D and increased parathyroid hormone levels in old age. Eur Psychiatr. 2009;24(S1):1–1. doi: 10.1016/S0924-9338(09)70550-4. [DOI] [PubMed] [Google Scholar]
28.Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65(5):508–512. doi: 10.1001/archpsyc.65.5.508. [DOI] [PubMed] [Google Scholar]
29.Kalueff A, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P. The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord-Drug Targets. 2006;5(3):363–371. doi: 10.2174/187152706784111506. [DOI] [PubMed] [Google Scholar]
30.Khan AH, Iqbal R, Naureen G, Dar FJ, Ahmed FN. Prevalence of vitamin D deficiency and its correlates: results of a community-based study conducted in Karachi. Pak Arch osteoporos. 2012;7(1):275–282. doi: 10.1007/s11657-012-0108-x. [DOI] [PubMed] [Google Scholar]
31.Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243–247. doi: 10.1038/cmi.2010.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Lapid MI, Cha SS, Takahashi PYJC. Vitamin D and depression in geriatric primary care patients. Clin Interv Aging. 2013 doi: 10.2147/CIA.S42838. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949–1956. doi: 10.1016/j.jacc.2008.08.050. [DOI] [PubMed] [Google Scholar]
34.Lopez RB, Denny BT, Fagundes CPJN, Reviews B. Neural mechanisms of emotion regulation and their role in endocrine and immune functioning a review with implications for treatment of affective disorders. Neurosci Biobehav Rev. 2018;95(508):514. doi: 10.1016/j.neubiorev.2018.10.019. [DOI] [PubMed] [Google Scholar]
35.McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008;22(4):982–1001. doi: 10.1096/fj.07-9326rev. [DOI] [PubMed] [Google Scholar]
36.Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and depression: a critical appraisal of the evidence and future directions. Indian J Psychol Med. 2020;42(1):11–21. doi: 10.4103/IJPSYM.IJPSYM_160_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010;95(7):3225–3233. doi: 10.1210/jc.2010-0347. [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M. Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res Paediatr. 2005;64(3):144–148. doi: 10.1159/000088588. [DOI] [PubMed] [Google Scholar]
39.Naveilhan P, Neveu I, Wion D, Brachet P. 1, 25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 1996;7(13):2171–2175. doi: 10.1097/00001756-199609020-00023. [DOI] [PubMed] [Google Scholar]
40.Newmark HL, Newmark J. Vitamin D and Parkinson's disease—a hypothesis. Mov Disord. 2007;22(4):461–468. doi: 10.1002/mds.21317. [DOI] [PubMed] [Google Scholar]
41.Oudshoorn C, Mattace-Raso F, van der Velde N, Colin E, Van der Cammen T. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with alzheimer’s disease. Dement Geriatr Cogn Disord. 2008;25(6):539–543. doi: 10.1159/000134382. [DOI] [PubMed] [Google Scholar]
42.Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152(5):307–314. doi: 10.7326/0003-4819-152-5-201003020-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Poskitt E, Cole T, Lawson D. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J. 1979;1(6158):221–223. doi: 10.1136/bmj.1.6158.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007;460(2):202–205. doi: 10.1016/j.abb.2006.12.018. [DOI] [PubMed] [Google Scholar]
45.Rajakumar K, Greenspan SL, Thomas SB, Holick MF. SOLAR ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health. 2007;97(10):1746–1754. doi: 10.2105/AJPH.2006.091736. [DOI] [PMC free article] [PubMed] [Google Scholar]
46.Rolf L, Muris AH, Hupperts R, Damoiseaux JJA. Vitamin D effects on B cell function in autoimmunity. Ann N Y Acad Sci. 2014;1317(1):84–91. doi: 10.1111/nyas.12440. [DOI] [PubMed] [Google Scholar]
47.Ross AC, Caballero B, Cousins RJ, Tucker KL. Modern nutrition in health and disease, vol. 123. Jones & Bartlett Learning; 2020, p. 1234-1246.
48.Stone A, Rogers D, Kruckenberg S, Lieser A. Impact of the mental healthcare delivery system on California emergency departments. West J Emerg Med. 2012;13(1):51. doi: 10.5811/westjem.2011.6.6732. [DOI] [PMC free article] [PubMed] [Google Scholar]
49.van Etten E, Mathieu CJTJ. Immunoregulation by 1 25-dihydroxyvitamin D3 basic concepts. J steroid Biochem Mol biol. 2005;97(1–2):93–101. doi: 10.1016/j.jsbmb.2005.06.002. [DOI] [PubMed] [Google Scholar]
50.Vasiliadis H-M, Lesage A, Adair C, Wang PS, Kessler RC. Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv. 2007;58(1):63–71. doi: 10.1176/ps.2007.58.1.63. [DOI] [PubMed] [Google Scholar]
51.Vogelzangs N, Beekman A, De Jonge P, Penninx BJTp. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):e249–e249. doi: 10.1038/tp.2013.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
52.Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14(12):1032–1040. doi: 10.1097/01.JGP.0000240986.74642.7c. [DOI] [PubMed] [Google Scholar]
53.Yetley EA, Brulé D, Cheney MC, Davis CD, Esslinger KA, Fischer PW, Klurfeld DM. Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr. 2009;89(3):719–727. doi: 10.3945/ajcn.2008.26903. [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):552–572. doi: 10.1079/BJN2003837. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12991_2022_406_MOESM1_ESM.docx^{(16.5KB, docx)}

Additional file 1: Table S1. Reference Ranges for 25 (OH) D (Ferrari, Lombardi, & Banfi, 2017).

Data Availability Statement

All the data is contained in the manuscript.

[CR1] 1.Allen CK, Austin SL, David SK, MHE O, McCraith Riska-Williams DB. Manual for the allen cognitive level screen-5 (ACLS-5) and large allen cognitive level screen-5 (LACLS-5) LJJOT. 2007;56:609–639. [Google Scholar]

[CR2] 2.Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Féron F. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics. 2007;7(5):769–780. doi: 10.1002/pmic.200600392. [DOI] [PubMed] [Google Scholar]

[CR3] 3.Anjum I, Jaffery SS, Fayyaz M, Samoo Z, Anjum SJC. The role of vitamin D in brain health a mini literature review. Cureus. 2018 doi: 10.7759/cureus.2960. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR4] 4.Aslam M, Masood Z, Sattar A, Qudsia M. Vitamin D deficiency. Prof Med J. 2012;19(02):208–213. [Google Scholar]

[CR5] 5.Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu CJC. Vitamin D modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–496. doi: 10.1016/j.coph.2010.04.001. [DOI] [PubMed] [Google Scholar]

[CR6] 6.Barnard K, Colón-Emeric CJTA. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010;8(1):4–33. doi: 10.1016/j.amjopharm.2010.02.004. [DOI] [PubMed] [Google Scholar]

[CR7] 7.Beck AT, Steer RA, Brown GK. Beck depression inventory (BDI-II) London: Pearson; 1996. [Google Scholar]

[CR8] 8.Bhimani MMJJ. Vitamin D does it play a role in psychiatry. J Pak Med Assoc. 2012;62(2):181. [PubMed] [Google Scholar]

[CR9] 9.Bosomworth N. Mitigating epidemic vitamin D deficiency: the agony of evidence. Can Fam Phys. 2011;57(1):16–20. [PMC free article] [PubMed] [Google Scholar]

[CR10] 10.Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008;13(1):6. [PubMed] [Google Scholar]

[CR11] 11.Chamorro L, Luque A, Lobo A. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton Anxiety rating scales. Med Clin. 2002;118(13):493–499. doi: 10.1016/S0025-7753(02)72429-9. [DOI] [PubMed] [Google Scholar]

[CR12] 12.Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Hoshen MBJB. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014 doi: 10.1136/bmj.g1903. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR13] 13.Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exerc Psychol. 1998;20(4):339–357. doi: 10.1123/jsep.20.4.339. [DOI] [Google Scholar]

[CR14] 14.Cusin C, Yang H, Yeung A, Fava M. Rating scales for depression. In: Lee B, Mark AB, editors. Handbook of clinical rating scales and assessment in psychiatry and mental health. Totowa: Humana Press; 2009. [Google Scholar]

[CR15] 15.Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Shaw JE. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol. 2012;77(1):26–35. doi: 10.1111/j.1365-2265.2011.04320.x. [DOI] [PubMed] [Google Scholar]

[CR16] 16.Di Cesare M, Bhatti Z, Soofi SB, Fortunato L, Ezzati M, Bhutta ZA. Geographical and socioeconomic inequalities in women and children's nutritional status in Pakistan in 2011: an analysis of data from a nationally representative survey. Lancet Glob Health. 2015;3(4):e229–e239. doi: 10.1016/S2214-109X(15)70001-X. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR17] 17.Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KLJ. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi: 10.1016/j.biopsych.2009.09.033. [DOI] [PubMed] [Google Scholar]

[CR18] 18.Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience. 2003;118(3):641–653. doi: 10.1016/S0306-4522(03)00040-X. [DOI] [PubMed] [Google Scholar]

[CR19] 19.Ferrari D, Lombardi G, Banfi GJ. Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement. Biochemia Medica. 2017;27(3):453–466. doi: 10.11613/BM.2017.030501. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR20] 20.Ganji V, Milone C, Cody MM, McCarty F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the third national health and nutrition examination survey. Int Arch Med. 2010;3(1):1–8. doi: 10.1186/1755-7682-3-29. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR21] 21.Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–261. doi: 10.2105/AJPH.2004.045260. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR22] 22.Harvey NC, Cooper C. Vitamin D: some perspective please in british medical journal publishing group. BMJ. 2012 doi: 10.1136/bmj.e4695. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR23] 23.Holick MF. Photosynthesis of vitamin D in the skin effect of environmental and life-style variables. In: Federation proceedings, Vol. 46, No. 5; 1987. p. 1876–1882. [PubMed]

[CR24] 24.Holick MF. High prevalence of vitamin D inadequacy and implications for health paper presented at the Mayo. Clin Proc. 2006 doi: 10.4065/81.3.353. [DOI] [PubMed] [Google Scholar]

[CR25] 25.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]

[CR26] 26.Hollis BW, Wagner CL. Vitamin D deficiency during pregnancy an ongoing epidemic. Oxford: Oxford University Press; 2006. [DOI] [PubMed] [Google Scholar]

[CR27] 27.Hoogendijk W, Beekman A, Deeg D, Lips P, Penninx BJ. Depression is associated with decreased 25-hydroxyvitamin-D and increased parathyroid hormone levels in old age. Eur Psychiatr. 2009;24(S1):1–1. doi: 10.1016/S0924-9338(09)70550-4. [DOI] [PubMed] [Google Scholar]

[CR28] 28.Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65(5):508–512. doi: 10.1001/archpsyc.65.5.508. [DOI] [PubMed] [Google Scholar]

[CR29] 29.Kalueff A, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P. The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord-Drug Targets. 2006;5(3):363–371. doi: 10.2174/187152706784111506. [DOI] [PubMed] [Google Scholar]

[CR30] 30.Khan AH, Iqbal R, Naureen G, Dar FJ, Ahmed FN. Prevalence of vitamin D deficiency and its correlates: results of a community-based study conducted in Karachi. Pak Arch osteoporos. 2012;7(1):275–282. doi: 10.1007/s11657-012-0108-x. [DOI] [PubMed] [Google Scholar]

[CR31] 31.Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243–247. doi: 10.1038/cmi.2010.73. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR32] 32.Lapid MI, Cha SS, Takahashi PYJC. Vitamin D and depression in geriatric primary care patients. Clin Interv Aging. 2013 doi: 10.2147/CIA.S42838. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR33] 33.Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency: an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949–1956. doi: 10.1016/j.jacc.2008.08.050. [DOI] [PubMed] [Google Scholar]

[CR34] 34.Lopez RB, Denny BT, Fagundes CPJN, Reviews B. Neural mechanisms of emotion regulation and their role in endocrine and immune functioning a review with implications for treatment of affective disorders. Neurosci Biobehav Rev. 2018;95(508):514. doi: 10.1016/j.neubiorev.2018.10.019. [DOI] [PubMed] [Google Scholar]

[CR35] 35.McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008;22(4):982–1001. doi: 10.1096/fj.07-9326rev. [DOI] [PubMed] [Google Scholar]

[CR36] 36.Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and depression: a critical appraisal of the evidence and future directions. Indian J Psychol Med. 2020;42(1):11–21. doi: 10.4103/IJPSYM.IJPSYM_160_19. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR37] 37.Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010;95(7):3225–3233. doi: 10.1210/jc.2010-0347. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR38] 38.Moussavi M, Heidarpour R, Aminorroaya A, Pournaghshband Z, Amini M. Prevalence of vitamin D deficiency in Isfahani high school students in 2004. Horm Res Paediatr. 2005;64(3):144–148. doi: 10.1159/000088588. [DOI] [PubMed] [Google Scholar]

[CR39] 39.Naveilhan P, Neveu I, Wion D, Brachet P. 1, 25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 1996;7(13):2171–2175. doi: 10.1097/00001756-199609020-00023. [DOI] [PubMed] [Google Scholar]

[CR40] 40.Newmark HL, Newmark J. Vitamin D and Parkinson's disease—a hypothesis. Mov Disord. 2007;22(4):461–468. doi: 10.1002/mds.21317. [DOI] [PubMed] [Google Scholar]

[CR41] 41.Oudshoorn C, Mattace-Raso F, van der Velde N, Colin E, Van der Cammen T. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with alzheimer’s disease. Dement Geriatr Cogn Disord. 2008;25(6):539–543. doi: 10.1159/000134382. [DOI] [PubMed] [Google Scholar]

[CR42] 42.Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152(5):307–314. doi: 10.7326/0003-4819-152-5-201003020-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR43] 43.Poskitt E, Cole T, Lawson D. Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J. 1979;1(6158):221–223. doi: 10.1136/bmj.1.6158.221. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR44] 44.Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007;460(2):202–205. doi: 10.1016/j.abb.2006.12.018. [DOI] [PubMed] [Google Scholar]

[CR45] 45.Rajakumar K, Greenspan SL, Thomas SB, Holick MF. SOLAR ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health. 2007;97(10):1746–1754. doi: 10.2105/AJPH.2006.091736. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR46] 46.Rolf L, Muris AH, Hupperts R, Damoiseaux JJA. Vitamin D effects on B cell function in autoimmunity. Ann N Y Acad Sci. 2014;1317(1):84–91. doi: 10.1111/nyas.12440. [DOI] [PubMed] [Google Scholar]

[CR47] 47.Ross AC, Caballero B, Cousins RJ, Tucker KL. Modern nutrition in health and disease, vol. 123. Jones & Bartlett Learning; 2020, p. 1234-1246.

[CR48] 48.Stone A, Rogers D, Kruckenberg S, Lieser A. Impact of the mental healthcare delivery system on California emergency departments. West J Emerg Med. 2012;13(1):51. doi: 10.5811/westjem.2011.6.6732. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR49] 49.van Etten E, Mathieu CJTJ. Immunoregulation by 1 25-dihydroxyvitamin D3 basic concepts. J steroid Biochem Mol biol. 2005;97(1–2):93–101. doi: 10.1016/j.jsbmb.2005.06.002. [DOI] [PubMed] [Google Scholar]

[CR50] 50.Vasiliadis H-M, Lesage A, Adair C, Wang PS, Kessler RC. Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv. 2007;58(1):63–71. doi: 10.1176/ps.2007.58.1.63. [DOI] [PubMed] [Google Scholar]

[CR51] 51.Vogelzangs N, Beekman A, De Jonge P, Penninx BJTp. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):e249–e249. doi: 10.1038/tp.2013.27. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR52] 52.Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14(12):1032–1040. doi: 10.1097/01.JGP.0000240986.74642.7c. [DOI] [PubMed] [Google Scholar]

[CR53] 53.Yetley EA, Brulé D, Cheney MC, Davis CD, Esslinger KA, Fischer PW, Klurfeld DM. Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr. 2009;89(3):719–727. doi: 10.3945/ajcn.2008.26903. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR54] 54.Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):552–572. doi: 10.1079/BJN2003837. [DOI] [PubMed] [Google Scholar]

PERMALINK

Vitamin D status and its correlation to depression

Bashir khan

Huma Shafiq

Seyyedha Abbas

Summeira Jabeen

Sikandar Ali Khan

Tayyaba Afsar

Ali Almajwal

Nawaf W Alruwaili

Dara al-disi

Sultan Alenezi

Zahida Parveen

Suhail Razak

Abstract

Background

Methods

Results

Conclusions

Supplementary Information

Background

Methods

Participants

Study protocol

Study design (descriptive)

Inclusion criteria

Exclusion criteria

Sampling technique

Collection of blood samples

Determination of vitamin D level

Identification of depressed and normal subjects

Estimation of level of depression

Results

Table 1.

Vitamin D profile of 100 normal subjects (males and females)

Table 2.

Age, vitamin D and depression profile of 100 subjects with depression (male and female)

Table 3.

Depression and vitamin D profile of subjects of 20 years and below (Group-I)

Table 4.

Depression and vitamin D profile of subjects between 21 and 60 years (Group-II)

Table 5.

Depression and vitamin D profile of 61 years and above subjects (Group III)

Table 6.

Table 7.

Discussion

Conclusions

Limitations of our study

Supplementary Information

Acknowledgements

Abbreviations

Author contributions

Funding

Availability of data and materials

Declarations

Ethical approval and consent to participate

Consent for publication

Competing interests

Footnotes

Contributor Information

References

Associated Data

Supplementary Materials

Data Availability Statement

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases